| 09.00am | Arrival, Registration, Coffee & Tea | |
| 09.45am | Chairman's Welcome & Introduction | Allan Karr, Chairman,PDIG Margaret Dolan, Vice Chairman, PDIG |
| 10.00am | Pharma Industry and NHS Relations - Can we work together? - What is the new guidance on joint working?
- Can the Industry survive PPRS?
- What are the key drivers for change?
| David Fisher, ABPI, Commercial Director
» View Slides |
| 10.45am | Risk Management or Patient Access Programmes - are the views of Pharma and Practitioners the same? - What are the strategic issues driving risk sharing schemes?
- How do the key stakeholders view the schemes?
- Do risk sharing schemes work?
|
| Dr Rafiq Hassan
Head of Market Access, juneartis
Kevan Wind
Medicines Procurement Specialist Pharmacist, London & East of England
» View Slides |
| 11.30am | Tea/Coffee
| |
| 12.00 noon | A Review of the Supply Chain Model - What is happening to the supply chain?
- Who are the winners and losers?
- What will the supply chain look like in the future?
| Michael Thomas
Principal, A.T. Kearney Ltd
» View Slides |
| 12.45pm | David Samways Award | |
| 12.50pm | Lunch
| |
| 2.00pm | How do Pharma set the prices of their medicines? - What factors influence the cost of medicines?
- Do we get value from the cost of our medicines?
- Why do Orphan medicines cost so much?
| Donald Macarthur
Indepenent Consultant
» View Slides |
| 2.45pm | Purchasing new products to assist implementation of NPSA injectable guidance - What are the problems with the medicines we purchase today?
- Why can’t we get the medicines we want?
- How do we contract for the medicines of the future?
| Dr Clare Crowley
Medicines Safety Pharmacist, Oxford Radcliffe Hospitals NHS Trust
» View Slides |
| 3.15pm | The Chain Reaction - Pandemic flu – myth or reality?
- How will the supply chain cope?
- What are key strategic measures that will affect the whole supply chain?
| Michael Young,
Medicines, Pharmacy, Industry Dept (MPI), DoH
» View Slides |
| 4.00pm | Close |